Apyx Medical

Apyx Medical

APYX· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +121.5% in FY2025

Charles D. Goodwin is the CEO of Apyx Medical and was paid $1.2M in FY2025 (Dec), up 26%.

Pay$100 in the stock at the end of FY21 → $27
CEO pay is from each Apyx Medical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Charles D. GoodwinFY2025
  2. 2Mathew HillFY2025
  3. 3Shawn RomanFY2025
  4. 4Moshe CitronowiczFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Apyx Medical paid its 4 named executives $3.2M in total in FY2025 (Dec). CEO Charles D. Goodwin was paid $1.2M of that.

Name
Charles D. GoodwinCEO and Director
Mathew HillCFO, Treasurer and Secretary
Shawn RomanChief Operating OfficerNot disclosed
Moshe CitronowiczSenior Vice President

of each named executive, from the Summary Compensation Table of each proxy.

Peers11

See all

The FY2025 (Dec) proxy of Apyx Medical names 11 peer companies for pay. Among Apyx Medical and these peers, CEO pay was 2nd highest of 3 and total shareholder return was 2nd highest of 3.

2nd highest of 3in Apyx Medical and its pay peers, FY2025 (Dec) by CEO pay:

$808.4K$1.5M

2nd highest of 3in Apyx Medical and its pay peers, FY2025 (Dec) by total shareholder return:

$12$228

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Minnie Baylor-HenryDirector · 6 yr on the boardIndependentAudit, Compensation, Governance and Nominating, Regulatory Compliance (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A

Filings6

See all
Proxy statementDEF 14AJun 26, 2026FY2025
Annual report10-KMar 10, 2026FY2025
Proxy statementDEF 14AJun 25, 2025FY2024
Annual report10-KMar 13, 2025FY2024
Proxy statementDEF 14AJun 25, 2024FY2023
Annual report10-KMar 21, 2024FY2023